Skip to the page

Data / Form D filings / Fieldstone Bio, Inc.

Fieldstone Bio, Inc.: Form D filing

Fieldstone Bio, Inc., a technology company in Andover, MA, filed a Form D with the SEC in 2025. The latest, on January 31, 2025, reports $5.9 million sold of a $5.9 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10 STEVENS STREET #2036, Andover, MA, 01810
Phone
(617) 299-9682
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2052482

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 31, 2025New notice$5,919,997$5,919,9973Dec 16, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Patrick StoneExecutive Officer, Director
Calvin ChinDirector
Brandon FieldsDirector

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Jan 27, 2025 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Fieldstone Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.